Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate, different dendritic and T-cell subsets

被引:68
作者
Parajuli, P
Mosley, RL
Pisarev, V
Chavez, J
Ulrich, A
Varney, M
Singh, RK
Talmadge, JE
机构
[1] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Lab Transplantat Immunol, Omaha, NE 68198 USA
[2] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Neurol Surg, Detroit, MI USA
关键词
D O I
10.1016/S0301-472X(01)00722-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Mechanisms of T-cell stimulation by Flt3 ligand (Flt3L) and granulocyte-macrophage colony-stimulating factor (GM-CSF) remain unclear. Herein, we compared the effects of Flt3L and GM-CSF on the expansion of dendritic cells (DC) and T-cell subsets and cytokine expression. Methods. Naive and effector/memory T cells were analyzed by flow cytometry (FC). CD4(+) and CD8(+) T cells and CD11c(+)CD11(dull/-)(DC1) and CD11c(+)CD11b(+) (DC2) subsets were isolated and the frequency of IFN-gamma-, IL-12- (type 1) and IL-4-, IL-10 (type 2)-producing cells and cytokine mRNA expression evaluated. Results. Flt3L expanded both DC1 and DC2 subsets with a significantly higher percentage and number of DC1 than DC2, while GM-CSF preferentially expanded the DC2 subset. Isolated DC1 from Flt3L-injected mice had significantly higher levels of IL-12 (p40) than IL-10, while the converse occurred with DC2. The numbers of naive and memory T cells were elevated in mice that received Flt3L or GM-CSF. However, the number of memory CD4(+) and CD8(+) T cells was significantly increased in Flt3L as compared to GM-CSF cohorts. While GM-CSF increased the frequency of both type 1 and type 2 cytokine-producing cells, Flt3L significantly augmented the frequency of type 1 T cells. Conclusions. In contrast to GM-CSF, FIt3L preferentially induces the expansion of type 1 T cells. The mechanism of Flt3L-induced T-cell stimulation is associated with the expansion of the IL-12 (p40)-producing DC1 and memory T cells. (C) 2001 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1185 / 1193
页数:9
相关论文
共 47 条
[1]   Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor [J].
Armitage, JO .
BLOOD, 1998, 92 (12) :4491-4508
[2]  
Ashihara E, 1998, EUR J HAEMATOL, V60, P86
[3]  
BOST KL, 1995, J IMMUNOL, V154, P718
[4]  
Bouloc A, 2000, EUR J IMMUNOL, V30, P3132, DOI 10.1002/1521-4141(200011)30:11<3132::AID-IMMU3132>3.0.CO
[5]  
2-E
[6]   Hematologic effects of flt3 ligand in vivo in mice [J].
Brasel, K ;
McKenna, HJ ;
Morrissey, PJ ;
Charrier, K ;
Morris, AE ;
Lee, CC ;
Williams, DE ;
Lyman, SD .
BLOOD, 1996, 88 (06) :2004-2012
[7]   Flt3 ligand antitumor activity in a murine breast cancer model: A comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action [J].
Braun, SE ;
Chen, KY ;
Blazar, BR ;
Orchard, PJ ;
Cornetta, K .
HUMAN GENE THERAPY, 1999, 10 (13) :2141-2151
[8]   Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization [J].
Cella, M ;
Facchetti, F ;
Lanzavecchia, A ;
Colonna, M .
NATURE IMMUNOLOGY, 2000, 1 (04) :305-310
[9]  
Chen KY, 1997, CANCER RES, V57, P3511
[10]   Polyethylene glycol-modified GM-CSF expands CD11bhighCD11chigh but not CD11blowCD11chigh murine dendritic cells in vivo:: A comparative analysis with Flt3 ligand [J].
Daro, E ;
Pulendran, N ;
Brasel, K ;
Teepe, M ;
Pettit, D ;
Lynch, DH ;
Vremec, D ;
Robb, L ;
Shortman, K ;
McKenna, HJ ;
Maliszewski, CR ;
Maraskovsky, E .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :49-58